FindTrial
Sign In

study to assess efficacy and safety of Skinoren 15% gel and Differin 0.1 % gel for the treatment and maintenance treatment of facial acne vulgaris and late-type acne in females

An evaluator-blind controlled parallel-group study to assess efficacy and safety of Skinoren 15% gel and Differin 0.1 % gel for the treatment and maintenance treatment of facial acne vulgaris and late-type acne in females - SKADI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-000152-42-DE
Enrollment
Unknown
Registered
2011-06-20
Start date
2011-07-07
Completion date
Unknown
Last updated
2012-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne vulgaris late type acne

Interventions

Trade Name: Skinoren 15% Gel Product Name: SKINOREN 15 % Gel Product Code: 002902-C990 Pharmaceutical Form: Gel Pharmaceutical Form:

Sponsors

Medical Faculty, University Magdeburg
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -female subjects -between 18 and 45 years of age -diagnosis of mild to moderate acne vulgaris and/or late-type acne -presence of microcomedoness on a cyanoacrylate strip (CyASt) Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 60 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: pregnancy

Design outcomes

Primary

MeasureTime frame
Main Objective: to assess the effect of Skinoren 15% gel compared to no therapy on the maintenance of clinical therapy success in subjects with mild to moderate acne vulgaris previously treated for 3 months by monotherapy of this substance and to assess the effect of Skinoren 15%, compared to Differin 0.1 %gel, on the efficacy and safety during a 9-month long-term treatment period.;Secondary Objective: ;Primary end point(s):—

Countries

Germany

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026